Andrew S Boyer is Executive Vice President of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 256,670 shares of AMRX, which is worth approximately $2.1 Million. The most recent transaction as insider was on Jun 30, 2021, when has been sold 11,583 shares (Class A Common Stock) at a price of $5.12 per share, resulting in proceeds of $59,305. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 257K
19.64% 3M change
4.87% 12M change
Total Value Held $2.1 Million

ANDREW S BOYER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2021
SELL
Payment of exercise price or tax liability
$59,305 $5.12 p/Share
11,583 Reduced 7.11%
151,262 Class A Common Stock
Jun 30 2021
BUY
Exercise of conversion of derivative security
-
23,095 Added 12.42%
162,845 Class A Common Stock
May 07 2021
SELL
Payment of exercise price or tax liability
$43,436 $5.2 p/Share
8,353 Reduced 5.64%
139,750 Class A Common Stock
May 07 2021
BUY
Exercise of conversion of derivative security
-
16,655 Added 10.11%
148,103 Class A Common Stock
Mar 01 2021
SELL
Payment of exercise price or tax liability
$32,075 $5.18 p/Share
6,192 Reduced 4.5%
131,448 Class A Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
-
12,346 Added 8.23%
137,640 Class A Common Stock
Feb 27 2021
SELL
Payment of exercise price or tax liability
$87,862 $5.39 p/Share
16,301 Reduced 11.51%
125,294 Class A Common Stock
Feb 27 2021
BUY
Exercise of conversion of derivative security
-
31,662 Added 18.27%
141,595 Class A Common Stock
ASB

Andrew S Boyer

Executive Vice President
Bridgewater, NJ

Track Institutional and Insider Activities on AMRX

Follow Amneal Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX